Fundraising Fox

Renasant Bio

Berkeley, US · Founded 2022 · Delaware corporation · 3 known investors

Biotechin /renasant-bio@RenasantBio

Founders & leadership

EC
Evan CaplanDirector
NH
Natalie HollesDirector
CM
Charlotte McKeeDirector
TG
Thomas GustafsonExecutive Officer
AF
Anna FrenchDirector
EC
Emily ConleyExecutive Officer, Director
DP
Deborah PalestrantDirector
KB
Kevin BittermanDirector

Investors · 3

5AM VenturesBoston · $100K – $4M
OrbiMedNew York · $1M – $75M
Atlas VenturereportedCambridge · $500K – $1Mvia Kevin Bitterman · board

Reported raises · per SEC filings

Form D private placements
▶$25.5MraisedJul 2025 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Emily ConleyExecutive Officer, Director
  • Deborah PalestrantDirector
  • Evan CaplanDirector
  • Thomas GustafsonExecutive Officer
  • Kevin BittermanDirector
  • June LeeDirector
Offering amount
$25.5M
Amount sold
$25.5M
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30MraisedJul 2025 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Evan CaplanDirector
  • Natalie HollesDirector
  • Charlotte McKeeDirector
  • Deborah PalestrantDirector
  • Thomas GustafsonExecutive Officer
  • Anna FrenchDirector
  • Kevin BittermanDirector
  • Emily ConleyExecutive Officer, Director
Offering amount
$30M
Amount sold
$30M
First sale
Jun 2025
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.